AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong · Delayed Price · Currency is HKD 2.360
+0.020 (0.85%)
May 28, 2026, 11:43 AM HKT
AIM Vaccine Market Cap
AIM Vaccine has a market cap or net worth of 2.87 billion as of May 27, 2026. Its market cap has decreased by -33.33% in one year.
Market Cap
2.87B
Enterprise Value
4.63B
Revenue
1.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
2.36
Market Cap Chart
Since October 6, 2022, AIM Vaccine's market cap has decreased from 20.15B to 2.87B, a decrease of -85.76%. That is a compound annual growth rate of -41.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 2.87B | -27.10% |
| Dec 31, 2025 | 3.94B | -47.05% |
| Dec 31, 2024 | 7.44B | -21.78% |
| Dec 29, 2023 | 9.51B | -67.02% |
| Dec 30, 2022 | 28.82B | 43.02% |
| Oct 6, 2022 | 20.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Luzhu Biotechnology | 3.87B |
| Shandong Boan Biotechnology | 3.73B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.66B |
| BioDlink International Company | 3.53B |
| TYK Medicines | 3.44B |
| Clover Biopharmaceuticals | 3.25B |
| Jiangsu Recbio Technology | 3.08B |